Health Care & Life Sciences » Pharmaceuticals | Nantong Jinghua Pharmaceutical Co. Ltd.

Nantong Jinghua Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
40,673.30
40,627.30
81,842.00
173,459.60
190,326.30
260,069.40
Depreciation, Depletion & Amortization
25,183.70
39,643.70
45,724.10
59,854.10
63,949.00
79,755
Other Funds
4,950.00
682,713.30
97,940.70
12,401.00
6,090.30
41,187.40
Funds from Operations
83,842.60
81,023.80
137,937.10
226,994.20
352,531.80
372,797
Changes in Working Capital
141,662.20
39,493.20
213,948.70
116,807.50
276,609.20
286,827
Net Operating Cash Flow
57,819.60
41,530.60
76,011.60
343,801.70
75,922.60
85,969.90
Capital Expenditures
57,620.50
28,834.50
58,820.90
245,100.70
434,573.80
Sale of Fixed Assets & Businesses
3,290.70
11,177.20
19,853.20
4,472.50
167,136.80
Purchase/Sale of Investments
180.00
13,000.00
344,116.10
49,137.30
5.30
Net Investing Cash Flow
43,509.80
23,704.70
378,807.70
310,142.60
267,442.20
Cash Dividends Paid - Total
10,000.00
10,000.00
26,000.00
28,019.70
63,044.20
Issuance/Reduction of Debt, Net
57,200.00
39,000.00
10,000.00
90,000.00
268,922.80
Net Financing Cash Flow
42,250.00
711,713.30
61,940.70
130,420.60
199,788.20
Net Change in Cash
59,262.80
729,529.10
392,249.30
96,573.50
6,688.40
Free Cash Flow
115,440.10
12,696.10
134,832.50
98,701.00
358,651.20
Deferred Taxes & Investment Tax Credit
581.20
313.20
330.80
2,488.90
7,744.60
8,214.80
Net Assets from Acquisitions
-
-
-
23,177.10
-
Other Sources
11,000.00
7,872.60
4,366.60
2,800.00
-
Exchange Rate Effect
183.40
10.00
629.20
187.90
1,580.20
Other Uses
-
920.00
90.50
-
-

About Nantong Jinghua Pharmaceutical Co.

View Profile
Address
No. 9 Xingtai Road
Nantong Jiangsu 226005
China
Employees -
Website http://www.ntjhzy.com
Updated 07/08/2019
Nantong Jinghua Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceuticals as well as involves in the research, development and sale of active pharmaceutical ingredients and intermediaries. Its products include Alendronate sodium, Alendronic acid, Benzobarbital, Azelaic acid, Moxonidine, Lornoxicam, Meloxicam, Piroxicam, and Strontium ranelate. The company was founded on January 3, 1994 and is headquartered in Nantong, China.